Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy; Immuron is seeking a partner to support clinical development through regulatory approval and ...
Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and ...
Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...
As school holidays usher in later bedtimes and increased screen time, the structured rhythm of term-time often gives way to a more relaxed schedule. While this newfound freedom can initially excite ...
Morning Overview on MSN
Scientists edited human embryo genes with startling precision, researchers report
Two separate research teams used base editing to make single-nucleotide changes in human embryos this month, targeting genes ...
Business transformation is AI’s great promise, but according to Deloitte, deploying new tools is the easy part. To define and ...
Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results